Deep Posterior Post Gluteal Compartment Block in Total Hip Arthroplasty: Feasability and Safety
Launched by QUINCY ANESTHÉSIE · Mar 19, 2025
Trial Information
Current as of April 30, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a new way to help manage pain for patients undergoing total hip replacement surgery, also known as total hip arthroplasty. Researchers want to see if using a special type of nerve block, combined with an existing technique, can provide better pain relief than the typical methods used today. The goal is to help patients feel more comfortable, reduce the need for strong pain medications, and help them recover faster after their surgery.
To participate in this trial, you would need to be an adult who is scheduled to have total hip arthroplasty. However, not everyone can join; for example, if you have certain medical conditions that make regional anesthesia unsafe, have allergies to the medications used, or choose not to receive the injection, you would not be eligible. If you take part, you can expect to receive a combination of pain management techniques during your surgery, and the researchers will monitor your recovery, looking closely at your pain levels and any side effects. This trial is not yet recruiting participants, but it aims to improve the overall experience for future hip surgery patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • All adults with total hip arthroplasty
- • -
- Exclusion Criteria:
- • Contraindication to regional anesthesia
- • allergy
- • refusal of the injection
About Quincy Anesthésie
Quincy Anesthésie is a leading clinical trial sponsor specializing in the development and evaluation of innovative anesthetic techniques and medications. With a commitment to enhancing patient safety and improving surgical outcomes, Quincy Anesthésie conducts rigorous research studies that adhere to the highest ethical and scientific standards. The organization collaborates with healthcare professionals and institutions to advance the field of anesthesiology, aiming to translate research findings into practical applications that benefit both patients and practitioners. Through its dedication to excellence, Quincy Anesthésie plays a pivotal role in shaping the future of anesthesia care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
yoann ELMALEH, M.D
Principal Investigator
Hopital Privé Claude Galien
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported